NMN and NAD+: Aging Biology and What Current Studies Show

Why NAD+ Matters for Aging

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell of the body. It serves two essential functions:

1. Electron transfer in energy metabolism — NAD+ accepts electrons during glycolysis and the citric acid cycle, driving ATP production in mitochondria
2. Substrate for signaling enzymes — NAD+ is consumed as a substrate by sirtuins (SIRT1–7), PARPs (DNA repair enzymes), and other proteins that regulate inflammation, DNA repair, stress response, and circadian rhythm

The critical finding that launched the NMN/NR longevity space: NAD+ levels decline with age — by roughly 50% between young adulthood and middle age, and further into old age. This decline appears to impair cellular energy production, DNA repair capacity, and sirtuin activity.

Researchers like David Sinclair at Harvard and Shin-ichiro Imai at Washington University have proposed that restoring NAD+ levels may reverse or slow aspects of cellular aging.

NAD+ Precursors: The Pathway

The body cannot absorb NAD+ directly from supplements — it's degraded in the gut. Instead, NAD+ is synthesized from precursors via salvage pathways.

The main supplemental precursors:

NMN and NR are the most commercially marketed for longevity because they are closer to NAD+ in the synthesis pathway and theoretically more efficient, though this doesn't automatically mean they produce higher NAD+ levels.

Animal Research: What Excited Researchers

The preclinical findings in mice were striking:

• A landmark 2013 study by Yoshino et al. (Cell Metabolism) found that NMN administration in mice reversed age-related energy metabolism decline and restored muscle NAD+ levels.
• A 2016 study by Mills et al. found NMN supplementation in aging mice improved energy metabolism, physical activity, insulin sensitivity, and eye function, and extended lifespan modestly.
• Imai's lab has published multiple studies showing NMN's effects on vascular aging, muscle function, and mitochondrial biogenesis in rodents.

The important caveat: mouse models age differently from humans, and many compounds that extend mouse lifespan haven't translated to human benefit. Mice have very high basal metabolic rates and different NAD+ biology.

Human Clinical Trials

Elysium NR Trial (2018)

A double-blind, placebo-controlled trial (Trammell et al., Nature Communications, 2016; Dellinger et al., 2017) found NR (250mg twice daily) increased blood NAD+ levels by ~40–60% in healthy middle-aged adults. This was important proof that NAD+ precursor supplementation actually raises blood NAD+.

What it showed: Blood NAD+ goes up with supplementation. What this means for aging outcomes remains to be established.

NMN Human Trial — Imai Lab (2021)

The first major human RCT of NMN by Imai et al. (Science, 2021, n=25 older men) found that 250mg/day of NMN for 10 weeks:

• Significantly increased blood NAD+ levels
• Improved skeletal muscle insulin sensitivity (insulin-stimulated glucose uptake in muscle)
• Increased expression of muscle-related genes involved in NAD+ metabolism

This was an important milestone — actual physiological improvement in a relevant metabolic outcome in humans.

Washington University NMN Trial in Women (2021)

Yoshino et al. (Science, 2021) conducted an RCT in postmenopausal women with prediabetes (n=25) and found 250mg/day of NMN for 10 weeks improved insulin signaling in muscle and increased muscle expression of GLUT4 (a glucose transporter).

Other Human Trials

A 2022 randomized trial in GeroScience (Dollerup et al., modified NR protocol) found 2g/day of NR did not significantly change any cardiometabolic endpoints despite raising blood NAD+.

A growing number of trials are ongoing — including larger NMN studies examining cardiovascular outcomes, cognitive function, and physical performance in older adults.

The Regulatory Situation (NMN)

In late 2022, the FDA sent a warning letter to multiple NMN supplement companies, stating it had authorized NMN as an investigational new drug (IND) — which under FDA regulations means it cannot simultaneously be marketed as a dietary supplement.

The FDA effectively removed NMN from the dietary supplement market in the US in November 2022, though enforcement has been inconsistent and many products remain available. This is an active regulatory situation worth monitoring.

NR is not subject to this ruling and remains legal as a dietary supplement.

What to Make of This

The NMN/NAD+ longevity space sits in an interesting position: strong mechanistic rationale, compelling animal data, early positive human data for metabolic outcomes, but a long way from demonstrated longevity benefits in humans.

Related: NAD+ Precursors Compared: NMN vs. NR vs. Niacin · Telomere Health and Supplements: What Research Shows About TA-65, Astragalus, and Telomere Length · Intermittent Fasting Calculator

Related reading

• Resveratrol